![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 19, 17108-17111, May 10, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, February 8, 2002, and in revised form, February 19, 2002
In renal epithelial cells endocytosis of
Na+,K+-ATPase molecules is initiated by
phosphorylation of its In renal epithelial cells the
Na+,K+-ATPase is located within the basolateral
domain (1) and shuttles between the plasma membrane and intracellular
organelles during its regulation by G protein-coupled receptor signals
(2-6). In renal epithelial cells, inhibition of
Na+,K+-ATPase activity by
DA1 is mediated by the
removal of active molecules from the plasma membrane. This endocytic
traffic of Na+,K+-ATPase molecules to endosomal
compartments occurs via a clathrin vesicle-dependent
mechanism (2) and requires PKC. PKC Activation of PI 3-kinase is critical for
Na+,K+-ATPase endocytosis as it favors the
binding of AP-2 to the Materials--
Antibodies against GFP were purchased from
CLONTECH (Palo Alto, CA). Clathrin antibody was
from Oxford Biotechnology (Kidlington, UK). AP-2 antibody was obtained
from Upstate Biotechnology (Lake Placid, NY). Dopamine was purchased
from Solvay Pharmaceuticals GmbH (Hannover, Germany). All other
reagents were of highest available grade.
Plasmid Construction--
To obtain plasmid
pCMV.GFP-Na+,K+-ATPase we first introduced a
NruI site into the 5'-untranslated region of the
Cell Culture and Transfection--
OK cells were cultured in
Dulbecco's modified Eagle's medium (DMEM) (Invitrogen)
supplemented with 10% fetal calf serum, penicillin/streptomycin (100 IU/ml and 100 µg/ml, respectively) and 2 mM glutamine in a 5% CO2 incubator at 37 °C. Cells were transfected
with various expression constructs using the LipofectAMINE technique
(LipofectAMINE, Invitrogen) (14, 15). Two days after transfection the
cells were transferred to a medium containing 5 µM
ouabain (Sigma). Because the native
Na+,K+-ATPase is inhibited by this
concentration of ouabain, only OK cells expressing the transfected
rodent Determination of Na+,K+-ATPase
Activity--
Na+,K+-ATPase activity was
determined from the ouabain-inhibitable 86Rb+
transport (nmol of Rb/mg of protein/min). To assess the effect of DA,
cells were preincubated with 5 µM monensin (Sigma) for 30 min as described by Seri et al. (16) and then with 1 µM DA (5 min) before assay. Measurements of
Na+,K+-ATPase-mediated
86Rb+ transport were performed as described
previously (5, 15).
Preparation of Clathrin Vesicles--
Vesicles were isolated as
described previously (2, 17). Briefly, after incubation with 1 µM DA or vehicle (Hanks' medium), OK cells were
homogenized using a motor pestle homogenizer (Kimble-Kontes, Vineland,
NJ) in 1 mM EGTA, 0.5 mM MgCl2, 0.1 M Mes, and 0.2 mg/ml NaN3, titrated to pH 6.5 with NaOH. The homogenate was centrifuged at 85,000 × g for 1 h, and the pellet was resuspended in the same buffer and applied to a discontinuous sucrose gradient (w/v): 60%,
50%, 40%, 10%, and 5%. Samples were then centrifuged at 80,000 × g for 75 min and collected from the 10-40% interface;
they were then washed in homogenization buffer and centrifuged at
85,000 × g for 1 h. Wheat germ agglutinin was
added to a concentration of 1 mg:10 mg of protein and incubated
overnight at 4 °C. The agglutinated material was sedimented at
20,000 × g for 15 min.
Immunoprecipitation--
OK cells were incubated in the presence
or absence of 1 µM DA for 2 min at 25 °C. Thereafter,
the medium was replaced by immunoprecipitation buffer (in
mM: 100 NaCl, 50 Tris-HCl, 2 EGTA, 1 phenylmethylsulfonyl fluoride, 5 mg/ml of protease inhibitors (aprotinin, leupeptin, antipain), 1% Triton X-100 (pH 7.5)), and the samples were transferred to ice. The cells were disrupted by homogenization with a motor pestle
homogenizer. Immunoprecipitation of AP-2 was performed as described
previously (12). In brief, aliquots (500 µg protein) were
incubated overnight at 4 °C with 6 µg of a polyclonal antibody raised against the Confocal Microscopy--
Monitoring of GFP fluorescence was
performed as described previously (21). Briefly, OK cells expressing
the GFP-tagged Na+,K+-ATPase Statistical Analysis--
Comparison between two experimental
groups was made with the nonpaired Student's t test.
p < 0.05 was considered significant.
Using site-directed mutagenesis in intact cells we identified a
sequence within the Na+,K+-ATPase Clathrin-dependent endocytosis of
Na+,K+-ATPase molecules in response to G
protein-coupled receptor signals requires the interaction of AP-2 with
the Na+,K+-ATPase The tyrosine residues identified in all those potential AP-2 binding
motifs were initially mutated to phenylalanine. This mutation
eliminates only the hydroxyl groups but keeps the aromatic characteristic of the amino acid side chain. OK cell lines stably expressing the Na+,K+-ATPase bearing either of
these mutations were generated, and determination of
Na+,K+-ATPase activity (a reflection of
endocytosis, Ref. 9) in response to DA was used as read-out. Whereas
nonstimulated Na+,K+-ATPase activity was
similar in all groups (mutants and wild type), only OK cells expressing
the Na+,K+-ATPase-Y537F mutant demonstrated a
significant, although not complete, reduction in the inhibitory
response to DA (Fig. 1, right panel). We studied this motif
further by introducing a different mutation, Tyr537
Tyrosine 537 within the Na+,K+-ATPase
-Subunit Is Essential for AP-2 Binding and
Clathrin-dependent Endocytosis*
,
,
,
,
Department of Molecular Medicine, Karolinska
Institutet, The Rolf Luft Centrum for Diabetes Research, Karolinska
Hospital, 171 76 Stockholm, Sweden, the § College of
Pharmacy, University of Houston, Houston, Texas 77204, and the
¶ Department of Medicine, University of Chicago,
Chicago, Illinois 60637
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1-subunit, leading to activation
of phosphoinositide 3-kinase and adaptor protein-2 (AP-2)/clathrin
recruitment. The present study was performed to establish the identity
of the AP-2 recognition domain(s) within the
Na+,K+-ATPase
1-subunit. We
identified a conserved sequence (Y537LEL) within the
1-subunit that represents an AP-2 binding site. Binding
of AP-2 to the Na+,K+-ATPase
1-subunit in response to dopamine (DA) was increased in
OK cells stably expressing the wild type rodent
-subunit (OK-WT), but not in cells expressing the Y537A mutant (OK-Y537A). DA treatment was associated with increased
1-subunit abundance in
clathrin vesicles from OK-WT but not from OK-Y537A cells. In addition, this mutation also impaired the ability of DA to inhibit
Na+,K+-ATPase activity. Because phorbol esters
increase Na+,K+-ATPase activity in
OK cells, and this effect was not affected by the Y537A mutation, the
present results suggest that the identified motif is specifically
required for DA-induced AP-2 binding and Na+,K+-ATPase endocytosis.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-dependent phosphorylation of a serine (Ser18) residue within the
catalytic
1-subunit (7, 8) does not result in
inactivation of the enzyme while in the plasma membrane but is critical
for initiating its endocytosis (9). The resulting conformational
changes within the N-terminal segment of the
1-subunit (as a consequence of Ser18 phosphorylation) favor the
activation of class IA phosphoinositide 3-kinase (PI
3-kinase), possibly by promoting its interaction with a proline-rich
motif located upstream of the PKC phosphorylation site (10, 11).
1-subunit and thereby promotes
clathrin recruitment (11). While phosphorylation of the
1-subunit is important for activation of PI 3-kinase,
AP-2/clathrin recruitment, and endocytosis, the reversal of this effect
by other agonists does not appear to be controlled by dephosphorylation of the
-subunit (12). In contrast, G protein-coupled receptor signals that oppose Na+,K+-ATPase endocytosis,
such as
-adrenergic agonists, do so by increasing the levels of
inositol hexakisphosphate, thereby preventing the interaction of AP-2
with the Na+,K+-ATPase
-subunit (12). Thus,
regulation of the
1-subunit-AP-2 interactions appears to
be an important on/off mechanism for regulating Na+,K+-ATPase activity and its availability at
the plasma membrane in response to G protein-coupled receptor signals.
The present study was therefore performed to identify the
Na+,K+-ATPase
1-subunit
recognition domain(s) that interacts with AP-2.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-subunit of the rat Na+,K+-ATPase in
pCMVouabain (PharMingen) by site-directed mutagenesis. The GFP0
cDNA, which lacks the stop codon, was obtained from pB.CMV.GFP0 (13) and was inserted in-frame in pCMVouabain-NruI following digestion with NruI and ClaI. Mutants of the
un-tagged and the N-terminally GFP-tagged
Na+,K+-ATPase were created by site-directed
mutagenesis by exchanging nucleotides as follows: Y50F (TAC
versus TTC), Y255F (TAC versus TTC), Y469F (TAC
versus TTC), Y537F (TAC versus TTC), Y537A (TAC versus GCC), Y679F (TAC versus TTC), L499A (CTG
versus GCT), and L554A (CTT versus GCT). All
mutations were introduced by employing the QuikChange Mutagenesis
Kit from Stratagene, and oligonucleotides bearing the respective
nucleotide exchanges were synthesized at Genset. All constructs were
verified by DNA sequence analysis.
1-subunit survive. Therefore, the resistant
clones (expressing the transfected rat
1-subunit mutants) were expanded and grown in DMEM supplemented with 5 µM ouabain. Expression of the native
Na+,K+-ATPase
1-subunit was
negligible (7).
C subunit of AP-2 and the simultaneous addition of excess protein A-Sepharose beads (Amersham Biosciences,
Uppsala, Sweden). Protein content was determined according to
Bradford (18). Samples were analyzed by SDS-PAGE using the
Laemmli buffer system (19). Proteins were transferred to polyvinylidene
difluoride membranes (Immobilon-P, Millipore, Bedford, MA), and Western
blots were performed using an antibody against the
Na+,K+-ATPase
1-subunit (20) and
developed with an ECL Plus (Amersham Biosciences, Amersham, UK)
detection kit.
-subunit were
grown on 24-mm glass coverslips in supplemented DMEM. For fluorescence
imaging, the coverslip was placed in a perfusion chamber and mounted on
an inverted fluorescence microscope Leica DMIRB (Leica
Lasertechnik GmbH, Heidelberg, Germany). The cells were
maintained throughout the experiment in Hanks' medium at 37 °C. The
fluorescence of GFP-tagged Na+,K+-ATPase
-subunit was monitored by confocal laser scanning fluorescence microscopy using an argon/krypton laser at 488 nm (Leica TCS NT, Leica
Lasertechnik GmbH, Heidelberg, Germany). The following filter settings
were used: dichroic mirror TK 500, emission filter BP525/50, and 63×
lens (Leica PL APO 63×/1.32-0.6 oil). Images were processed using
Adobe Photoshop software.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-subunit
that interacts with AP-2 and demonstrated that this interaction is
essential for DA-dependent regulation of
Na+,K+-ATPase activity and endocytosis.
1-subunit (13,
14). The AP-2 molecules recognize and bind to short consensus motifs
present in membrane proteins to be internalized (22) and thereby
participate in the recruitment of clathrin to the site of endocytosis.
Many AP-2-target interactions involve the AP-2 µ-chain binding to a
consensus NPXY or YppØ motif (23), where Y is
tyrosine, X is any amino acid, p are preferentially positively charged residues, and Ø is a residue with a bulky
hydrophobic chain. Analysis of the
Na+,K+-ATPase
1-subunit sequence
revealed several intracellular sites for possible interaction with AP-2
(Fig. 1, left panel), whereas the
-subunit has one consensus motif that is located within the putative transmembrane domain.

View larger version (33K):
[in a new window]
Fig. 1.
Potential endocytic sequences within the
Na+,K+-ATPase
1-subunit. Several tyrosine
motifs were identified within the N terminus and the cytoplasmic loops
between M1-M2 and M4-M5 (left panel).
Na+,K+-ATPase activity was determined in OK
cells stably expressing the
1-subunit in which either
tyrosine residue was replaced by a phenylalanine (right
panel). Cells were incubated with 1 µM DA or vehicle
(Hanks' medium) for 5 min at 23 °C. Each bar represents
the mean + S.E. of six determinations performed in triplicate.
*, p < 0.05.
Ala
(Y537A); since alanine is an aliphatic amino acid the mutation, Tyr
Ala should totally eliminate any possible interaction between AP-2 and
the amino acid side chain. The experiments were performed in OK cells
stably expressing the rat Na+,K+-ATPase
1-isoform carrying a GFP tag at the N terminus (
-WT). The presence of this tag did not affect the basal nonstimulated Na+,K+-ATPase activity (Fig.
2A). Furthermore, DA decreased
enzyme activity (Fig. 2A), enhanced the interaction of the
1-subunit with AP-2 (Fig. 2B), and promoted
the endocytosis of active molecules in clathrin-coated vesicles (CCV)
(Fig. 2C). Introduction of the Y537A mutation (
-Y537A)
did not affect the level of
1-subunit expression, as
evident from images of the intrinsic GFP fluorescence using confocal
microscopy (Fig. 3A) and
Western blot analysis using a GFP- or
-subunit antibody (Fig.
3B).

View larger version (22K):
[in a new window]
Fig. 2.
Effect of DA on OK cells expressing stably
the Na+,K+-ATPase
1-subunit tagged with GFP.
A, OK cells (stably expressing the
1-subunit
with (open bars) or without (closed bars) GFP)
were incubated with 1 µM DA or vehicle (Hanks' medium)
for 5 min at 23 °C, and Na+,K+-ATPase
activity was determined. Each bar represents the mean + S.E.
of four independent determinations performed in triplicate.
**, p < 0.01. B, OK cells
transfected with the Na+,K+-ATPase bearing GFP
in it's
-subunit were incubated with DA as indicated in
A. Western blot analysis with an antibody against GFP
(1:500) was performed in the immunoprecipitated material obtained with
an AP-2 antibody. C, Na+,K+-ATPase
1-subunit abundance was determined by Western blot
analysis in CCV from OK cells expressing the
Na+,K+-ATPase
1-subunit bearing
GFP. Before CCV preparation, OK cells were treated with DA as described
in the legend to A. The data are representative of four
experiments.

View larger version (35K):
[in a new window]
Fig. 3.
Effect of DA on OK cells expressing the
Na+,K+-ATPase bearing the Y537A mutation in
the
-subunit. A,
confocal images of OK cells transfected with the
Na+,K+-ATPase
1-subunit bearing
the Y537A mutation (
-Y537A) or the wild type (
-WT). B,
Western blot analysis of cell homogenates (30 µg) performed with a
GFP antibody (1:500). C, determination of
Na+,K+-ATPase activity (nmol of Rb/mg of
protein/min) in OK cells treated with 1 µM DA for 5 min
at 23 °C (closed bars) or vehicle (Hanks' medium,
open bars). Bars represent the mean + S.E. of
four independent experiments performed in triplicate. *,
p < 0.05. D, OK cells transfected with the
Na+,K+-ATPase
-subunit wild type (
-WT) or
Y537A mutant (
-Y537A) were incubated with DA as indicated in
C. Western blot analysis was performed with an antibody
against the Na+,K+-ATPase
1-subunit in the immunoprecipitated material obtained
with an AP-2 antibody (left panel). Western blot was
performed with an AP-2 antibody in the immunoprecipitated material with
a Na+,K+-ATPase antibody (right
panel). E, Na+,K+-ATPase
1-subunit abundance in clathrin vesicles prepared from
cells that have been treated with 1 µM DA (5 min at
23 °C) or vehicle (Hanks' medium). Western blots were developed
with an antibody against GFP (1:500). Data are representative of five
independent experiments.
Cells expressing either the wild type or mutated GFP-tagged
Na+,K+-ATPase isoforms both had comparable
catalytic activity, determined as the rate of ouabain-sensitive
Rb+ transport in intact OK cells (Fig. 3C).
However, while DA inhibited Na+,K+-ATPase in OK
cells expressing the wild type
1-subunit, it failed to
induce a significant change in enzyme activity in OK cells expressing
the
-Y537A mutant (Fig. 3C). This mutation, contrary to
-Y537F, completely blocked the inhibitory effect of DA on Na+,K+-ATPase activity.
Co-immunoprecipitation assays were performed to further establish
whether the Y537A mutation has indeed rendered the
Na+,K+-ATPase catalytic
1-subunit unable to recognize AP-2 molecules, thus
leading to deficient endocytosis in response to DA (Fig. 3D). Incubation with DA increased the amount of
Na+,K+-ATPase
1-subunit
immunoprecipitated with an AP-2 antibody in
-WT, and, as predicted,
this interaction was absent in
-Y537A cells (Fig. 3D,
left panel). In another set of experiments, using the same
strategy, we demonstrated an increase in AP-2 from the immunoprecipitated material with a
Na+,K+-ATPase antibody in DA-treated
-WT,
but not
-Y537A, cells (Fig. 3D, right panel).
The sequence identified (Y537LEL) is highly conserved among
several species and Na+,K+-ATPase isoforms.
Because the two amino acids adjacent to Tyr are not positively charged
residues, the motif YLEL cannot be considered a typical "Tyr-based"
consensus sequence. Thus, it is possible that its interaction with AP-2
in intact cells and in response to a physiological agonist (dopamine)
may be facilitated by, or involve the presence of, other accessory
proteins present in the endocytic machinery. At present it is difficult
to establish the AP-2/Na+,K+-ATPase structural
relationship, although some predictions can be made. Whereas the
crystal structure of the Na+,K+-ATPase is still
unknown, the structure of skeletal muscle sarcoplasmic reticulum
calcium ATPase (SERCA)
1-subunit (which appears to share
many common structural features with the
Na+,K+-ATPase) has recently been determined
(24). The amino acids of SERCA corresponding to the
Na+,K+-ATPase sequence Y537LEL are
on the exterior of the molecule N-domain, which contains the nucleotide
binding site. If the site within the
Na+,K+-ATPase is as exposed as in the SERCA
molecule, it may suggests that it is the activation of AP-2 and not the
exposure of the "endocytic sequence" that is regulated by the
action of dopamine.
Because the decrease in Na+,K+-ATPase activity
elicited by DA is exclusively mediated by internalization of active
Na+,K+-ATPase molecules (9), we further
examined whether the absence of Tyr537 within the
1-subunit resulted in its deficient
clathrin-dependent endocytosis.
Na+,K+-ATPase
1-subunit
abundance in clathrin vesicles was determined in vesicles prepared from
-WT or
-Y537A cells that were previously treated with DA.
Characterization of CCV preparations was performed, and the results
were similar to the ones previously described in our laboratory (2).
The incubation time chosen (2.5 min) reflects the maximal incorporation
of Na+,K+-ATPase molecules in CCV obtained from
renal proximal tubule cells incubated with DA (2). DA treatment
significantly increased the Na+,K+-ATPase
abundance in
-WT, whereas it failed to do so in CCV derived from
-Y537A cells (Fig. 3E).
Na+,K+-ATPase immunoreactivity was present in
CCV prepared from the
-Y537A mutants despite lacking the ability to
bind AP-2. This could represent a population of
Na+,K+-ATPase molecules present in CCV that
originate from the recruitment pathway (recycling endosomes) in their
way to the plasma membrane (25). Because the latter is a process
that is mediated by AP-1, its interaction site within the
Na+,K+-ATPase appears not to be shared with the
AP-2 binding motif.
In contrast to DA, phorbol esters stimulate
Na+,K+-ATPase activity in OK cells (5, 15), and
this effect is mediated by increasing the number of
Na+,K+-ATPase molecules within the plasma
membrane (5). Interestingly, a phorbol ester (PMA) also stimulated
enzyme activity (nmol of Rb/mg of protein/min) in OK cells bearing the
Y537A mutation (
-WT, vehicle: 9.9 ± 0.6 versus 1 µM PMA, 16.3 ± 1.2 and
-Y537A; vehicle: 9.7 ± 0.7 versus 1 µM PMA, 14.0 ± 0.8, n = 3 in all groups), indicating that the stimulatory
mechanisms remained intact and that the Y537A mutation appears to
affect specifically the inhibitory response to DA. Additionally, these
results suggest that the interaction of AP-1 with the
Na+,K+-ATPase molecule that is needed for its
recruitment to the plasma membrane in response to phorbol esters (5)
requires a different recognition sequence within the
1-subunit.
Whereas the AP-2 µ-chain interacts with a NPXY or YppØ
motif, the
-chain of AP-2 recognizes instead dileucine motifs
(
)(2-4)xLL, where (
) is usually a negatively charged
residue and x a polar residue (22). Further analysis of the
Na+,K+-ATPase
1-subunit sequence
revealed the presence of two possible interacting dileucine motifs
(EPKHLL499 and L554LLPDE).
Na+,K+-ATPase activity was determined in
-WT
cells and in cells stably expressing the
1-subunit
carrying a mutation Leu499
Ala (
-L499A) or
Leu554
Ala (
-L554A). The presence of these mutations
within the Na+,K+-ATPase
1-subunit neither affected the inhibitory action of
dopamine nor the stimulatory effect of phorbol esters (Table
I).
|
In summary, the present study demonstrates the Y537LEL
motif as the recognition site within the
Na+,K+-ATPase molecule (catalytic
-subunit)
for its interaction with AP-2, a mandatory link in the signaling
cascade that translates G protein-coupled receptor activation into
clathrin-dependent endocytosis of
Na+,K+-ATPase molecules. Moreover, our data
indicate that this motif is not involved in the stimulation/recruitment
of Na+,K+-ATPase molecules
(AP-1-dependent) to the plasma membrane induced by phorbol
esters and supports the concept that endocytosis and recruitment are
two processes involving separate target motifs within the
Na+,K+-ATPase.
| |
ACKNOWLEDGEMENTS |
|---|
We thank M. J. Caplan for the gift of Na+,K+-ATPase antibody and T. Moede for useful discussions.
| |
FOOTNOTES |
|---|
* This work was supported in part by funds from the Swedish Research Council, the Swedish Heart and Lung Foundation, Åke Wibergs Stiftelse, Karolinska Institutet (to A. M. B.), Novo Nordisk Fond, National Institutes of Health Grant DK 53460, and by American Heart Association (Texas Affiliate) Grant 0050801Y (to C. H. P.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular
Medicine, L3, Karolinska Hospital, 171 76 Stockholm, Sweden. Tel.:
46-8-5177-9453; Fax: 46-8-5177-9450; E-mail:
Alejandro.Bertorello@molmed.ki.se.
Published, JBC Papers in Press, February 21, 2002, DOI 10.1074/jbc.M201326200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: DA, dopamine; AP-2, adaptor protein-2; PKC, protein kinase C; PI 3-kinase, phosphoinositide 3-kinase; OK, opossum kidney; GFP, green fluorescent protein, CCV, clathrin-coated vesicles; SERCA, skeletal muscle sarcoplasmic reticulum calcium ATPase; Mes, 2-(N-morpholino)ethanesulfonic acid; DMEM, Dulbecco's modified Eagle's medium; WT, wild type; PMA, phorbol 12-myristate 13-acetate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Caplan, M. J.
(1997)
Am. J. Physiol.
272,
F425-F429 |
| 2. |
Chibalin, A. V.,
Katz, A. I.,
Berggren, P.-O.,
and Bertorello, A. M.
(1997)
Am. J. Physiol.
273,
C1458-C1465 |
| 3. |
Carranza, M. L.,
Rousselot, M.,
Chibalin, A. V.,
Bertorello, A. M.,
Favre, H.,
and Féraille, E.
(1998)
J. Physiol. (Lond.)
511,
235-243 |
| 4. |
Bertorello, A. M.,
Ridge, K.,
Chibalin, A. V.,
Katz, A. I.,
and Sznajder, J. I.
(1999)
Am. J. Physiol.
276,
L20-L27 |
| 5. |
Efendiev, R.,
Bertorello, A. M.,
Pressley, T. A.,
Rousselot, M.,
Féraille, E.,
and Pedemonte, C. H.
(2000)
Biochemistry
39,
9884-9892[CrossRef][Medline]
[Order article via Infotrieve] |
| 6. |
Sweeney, G.,
Niu, W.,
Canfield, V.,
Levenson, R.,
and Klip, A.
(2001)
Am. J. Physiol.
281,
C1797-C1803 |
| 7. |
Chibalin, A. V.,
Pedemonte, C. H.,
Katz, A. I.,
Feraille, E.,
Berggren, P.-O.,
and Bertorello, A. M.
(1998)
J. Biol. Chem.
273,
8814-8819 |
| 8. |
Efendiev, R.,
Bertorello, A. M.,
and Pedemonte, C. H.
(1999)
FEBS Lett.
456,
45-48[CrossRef][Medline]
[Order article via Infotrieve] |
| 9. |
Chibalin, A. V.,
Ogimoto, G.,
Pedemonte, C. H.,
Pressley, T. A.,
Katz, A. I.,
Feraille, E.,
Berggren, P.-O.,
and Bertorello, A. M.
(1999)
J. Biol. Chem.
274,
1920-1927 |
| 10. |
Chibalin, A. V.,
Zierath, J. R.,
Katz, A. I.,
Berggren, P.-O.,
and Bertorello, A. M.
(1998b)
Mol. Biol. Cell
9,
1209-1220 |
| 11. |
Yudowski, G. A.,
Efendiev, R.,
Pedemonte, C. H.,
Katz, A. I.,
Berggren, P.-O.,
and Bertorello, A. M.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
6556-6561 |
| 12. |
Ogimoto, G.,
Yudowski, G. A.,
Barker, C. J.,
Köhler, M.,
Katz, A. I.,
Féraille, E.,
Pedemonte, C. H.,
Berggren, P.-O.,
and Bertorello, A. M.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
3242-3247 |
| 13. |
Moede, T.,
Leibiger, B.,
Pour, H. G.,
and Berggren, P.-O.
(1999)
FEBS Lett.
461,
229-234[CrossRef][Medline]
[Order article via Infotrieve] |
| 14. |
Rose, J. K.,
Buonocore, L.,
and Whitt, M. A.
(1991)
BioTechniques
10,
520-525[Medline]
[Order article via Infotrieve] |
| 15. |
Pedemonte, C. H.,
Pressley, T. M.,
Lokhandwala, M. F.,
and Cinelli, A. R.
(1997)
J. Membr. Biol.
155,
219-227[CrossRef][Medline]
[Order article via Infotrieve] |
| 16. |
Seri, I.,
Kone, B. C.,
Gullans, S. R.,
Aperia, A.,
Brenner, B. M.,
and Ballerman, B. J.
(1990)
Am. J. Physiol.
258,
F52-F60 |
| 17. |
Hammond, T. G.,
Verroust, P. J.,
Majewski, R. R.,
Muse, K. E.,
and Oberley, T. D.
(1994)
Am. J. Physiol.
267,
F516-F527 |
| 18. |
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve] |
| 19. |
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve] |
| 20. |
Pietrini, G.,
Matteoli, M.,
Banker, G.,
and Caplan, M.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
8414-8418 |
| 21. |
Leibiger, B.,
Moede, T.,
Schwarz, T.,
Brown, G. R.,
Kohler, M.,
Leibiger, I. B.,
and Berggren, P.-O.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9307-9312 |
| 22. |
Kirchhausen, T.
(1999)
Annu. Rev. Cell Dev. Biol.
15,
705-732[CrossRef][Medline]
[Order article via Infotrieve] |
| 23. |
Ohno, H.,
Stewart, J.,
Fournier, M.-C.,
Bosshart, H.,
Rhee, I.,
Miyatake, S.,
Saito, T.,
Gallusser, A.,
Kirchhausen, T.,
and Bonifacino, J. S.
(1995)
Science
269,
1872-1875 |
| 24. |
Toyoshima, C.,
Nakasako, M.,
Nomura, H.,
and Ogawa, H.
(2000)
Nature
405,
647-655[CrossRef][Medline]
[Order article via Infotrieve] |
| 25. |
Stoorvogel, W.,
Oorschot, V.,
and Geuze, H. J.
(1996)
J. Cell Biol.
132,
21-23 |
| 26. |
van Dam, E. M.,
and Stoorvogel, W.
(2002)
Mol. Biol. Cell
13,
169-182 |
This article has been cited by other articles:
![]() |
A. R. Cinelli, R. Efendiev, and C. H. Pedemonte Trafficking of Na-K-ATPase and dopamine receptor molecules induced by changes in intracellular sodium concentration of renal epithelial cells Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1117 - F1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Efendiev, C. E. Budu, A. M. Bertorello, and C. H. Pedemonte G-protein-coupled Receptor-mediated Traffic of Na,K-ATPase to the Plasma Membrane Requires the Binding of Adaptor Protein 1 to a Tyr-255-based Sequence in the {alpha}-Subunit J. Biol. Chem., June 20, 2008; 283(25): 17561 - 17567. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sjostrom, K. Stenstrom, K. Eneling, J. Zwiller, A. I. Katz, H. Takemori, and A. M. Bertorello SIK1 is part of a cell sodium-sensing network that regulates active sodium transport through a calcium-dependent process PNAS, October 23, 2007; 104(43): 16922 - 16927. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, R. T. Krmar, L. Dada, R. Efendiev, I. B. Leibiger, C. H. Pedemonte, A. I. Katz, J. I. Sznajder, and A. M. Bertorello Phosphorylation of Adaptor Protein-2 {micro}2 Is Essential for Na+,K+-ATPase Endocytosis in Response to Either G Protein-Coupled Receptor or Reactive Oxygen Species Am. J. Respir. Cell Mol. Biol., July 1, 2006; 35(1): 127 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Comellas, L. A. Dada, E. Lecuona, L. M. Pesce, N. S. Chandel, N. Quesada, G. R. S. Budinger, G. J. Strous, A. Ciechanover, and J. I. Sznajder Hypoxia-Mediated Degradation of Na,K-ATPase via Mitochondrial Reactive Oxygen Species and the Ubiquitin-Conjugating System Circ. Res., May 26, 2006; 98(10): 1314 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bertorello and J. I. Sznajder The Dopamine Paradox in Lung and Kidney Epithelia: Sharing the Same Target but Operating Different Signaling Networks Am. J. Respir. Cell Mol. Biol., November 1, 2005; 33(5): 432 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Efendiev, Z. Chen, R. T. Krmar, S. Uhles, A. I. Katz, C. H. Pedemonte, and A. M. Bertorello The 14-3-3 Protein Translates the NA+,K+-ATPase {alpha}1-Subunit Phosphorylation Signal into Binding and Activation of Phosphoinositide 3-Kinase during Endocytosis J. Biol. Chem., April 22, 2005; 280(16): 16272 - 16277. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Efendiev, R. T. Krmar, G. Ogimoto, J. Zwiller, G. Tripodi, A. I. Katz, G. Bianchi, C. H. Pedemonte, and A. M. Bertorello Hypertension-Linked Mutation in the Adducin {alpha}-Subunit Leads to Higher AP2-{micro}2 Phosphorylation and Impaired Na+,K+-ATPase Trafficking in Response to GPCR Signals and Intracellular Sodium Circ. Res., November 26, 2004; 95(11): 1100 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Khundmiri, A. M. Bertorello, N. A. Delamere, and E. D. Lederer Clathrin-mediated Endocytosis of Na+,K+-ATPase in Response to Parathyroid Hormone Requires ERK-dependent Phosphorylation of Ser-11 within the {alpha}1-Subunit J. Biol. Chem., April 23, 2004; 279(17): 17418 - 17427. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Efendiev, C. E. Budu, A. R. Cinelli, A. M. Bertorello, and C. H. Pedemonte Intracellular Na+ Regulates Dopamine and Angiotensin II Receptors Availability at the Plasma Membrane and Their Cellular Responses in Renal Epithelia J. Biol. Chem., August 1, 2003; 278(31): 28719 - 28726. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xie and T. Cai Na+-K+-ATPase-Mediated Signal Transduction: From Protein Interaction to Cellular Function Mol. Interv., May 1, 2003; 3(3): 157 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bertorello, Y. Komarova, K. Smith, I. B. Leibiger, R. Efendiev, C. H. Pedemonte, G. Borisy, and J. I. Sznajder Analysis of Na+,K+-ATPase Motion and Incorporation into the Plasma Membrane in Response to G Protein-coupled Receptor Signals in Living Cells Mol. Biol. Cell, March 1, 2003; 14(3): 1149 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Efendiev, G. A. Yudowski, J. Zwiller, B. Leibiger, A. I. Katz, P.-O. Berggren, C. H. Pedemonte, I. B. Leibiger, and A. M. Bertorello Relevance of Dopamine Signals Anchoring Dynamin-2 to the Plasma Membrane during Na+,K+-ATPase Endocytosis J. Biol. Chem., November 8, 2002; 277(46): 44108 - 44114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Pierre, M.-J. Duran, D. L. Carr, and T. A. Pressley Structure/function analysis of Na+-K+-ATPase central isoform-specific region: involvement in PKC regulation Am J Physiol Renal Physiol, November 1, 2002; 283(5): F1066 - F1074. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||